Current Neuropharmacology
Volume 18, 12 Issues, 2020
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
  |
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Neuropharmacology, Volume 3 - Number 1
Partial Dopamine Agonists and the Treatment of Psychosis
, 3(1): 3 - 8Carol A. Tamminga
DOI: 10.2174/1570159052773404
Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
, 3(1): 9 - 34Laura E. Chavez-Noriega, Michael J. Marino, Herve Schaffhauser, Una C. Campbell and P. Jeffrey Conn
DOI: 10.2174/1570159052773369
GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia
, 3(1): 45 - 62David W. Volk and David A. Lewis
DOI: 10.2174/1570159052773396
Selective Targeting of Muscarinic Receptors: Novel Therapeutic Approaches for Psychotic Disorders
, 3(1): 63 - 71Cyrille Sur and Gene G. Kinney
DOI: 10.2174/1570159052773413
Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs
, 3(1): 73 - 85W. Aichhorn, M. Gasser, E. M. Weiss, C. Adlassnig and J. Marksteiner
DOI: 10.2174/1570159052773440
Editor-in-Chief
F. Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
University Rome"da Sapienza"
Rome
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
Scopus CiteScore Metrics: 4.72
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net